r. Provisions and contingent liabilities / assets
The Company recognises a provision when there is a present obligation as a result of a past event that probably requires an outflow of resources and a reliable estimate can be made of the amount of the obligation. A disclosure for a contingent liability is made when there is a possible obligation or a present obligation that may, but probably will not, require an outflow of resources. Where there is a possible obligation or a present obligation that the likelihood of outflow of resources is remote, no provision or disclosure is made. Loss contingencies arising from litigation etc. are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated.
Contingent assets are neither recognised nor disclosed.
s. Earnings per Share
As per Accounting Standard 20 on Earnings Per Share, basic earnings per share are calculated by dividing the net profit or loss for the period in the shareholders' account by the weighted average number of equity shares outstanding during the period.
For the purpose of calculating diluted earnings per share, the net profit or loss for the year attributable to shareholders and the weighted average number of shares outstanding during the period are adjusted for the effects of all dilutive potential equity shares.
t. Cash and Cash Equivalents
Cash and cash equivalents for the purpose of Receipts and Payments Account comprises of cash and cheques in hand, bank balances, deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Receipts and Payments Account is prepared and reported using the Direct Method in accordance with Accounting Standard 3, Cash Flow Statements" as per requirements of the IRDAI AFI Master Circular 2024 and the IRDAI AFI Regulations 2024.
Notes:
Note 1:
Show-cause notices issued by various Government Authorities are not considered as an obligation. When any order or notice is raised by the authorities for which the Company is in appeal under adjudication, these are disclosed as contingent liability except in cases where the probability of any financial outflow is remote.
Note 2:
The IRDAI has issued directions under section 34 (1) of the Insurance Act, 1938 to refund allegedly excess commission paid to corporate agents amounting to ? 27,529 Lakhs (previous year ended March 31,2025: ? 27,529 Lakhs) to the members or the beneficiaries vide order no. IRDA/Life/ORD/Misc/083/03/2014 dated March 11, 2014. The SBI Life Insurance Company Limited ('the Company'), has preferred appeal against the order with the Securities Appellate Tribunal ('the SAT') for quashing the order passed by IRDAI as aforesaid. While deciding/ disposing off the appeal the SAT vide its order dated 29 January 2020 opined that the amount of ? 27,529 Lakhs has wrongly been calculated by the IRDAI and the appeal is partly allowed. The matter is remitted to the IRDAI to recalculate the unlawful gain, namely, the interest earned on advance premium collected and recover the same accordingly and pay it to the policyholders. However, the IRDAI recalculation, if any, has not been received by the Company instead the IRDAI preferred an appeal against the SAT order before the Hon'ble Supreme Court of India in Civil Appeal Nos. 254-255 of 2021. The Company has also
challenged the SAT order dated 29 January 2020 before the Hon'ble Supreme Court of India in Civil Appeal No. 2497-2498 of 2021, inter-alia praying for quashing the aforesaid order. At this juncture, the operation of the SAT order granting partial reliefs on quantum of disgorgement has been challenged in the Hon'ble Supreme Court by the IRDAI and the Company. Pending final adjudication of these cross appeals filed with the Hon'ble Supreme Court, the Company has considered entire disputed amount of ? 27,529 Lakhs as contingent liability.
Note 3:
These cases pertain to litigation arising in the ordinary course of business and pending at various appellate forums/courts. The Company has made a provision of ? 12,894 Lakhs at March 31, 2026 (Previous year ended March 31, 2025 ? 5,319 Lakhs) where the management assessment of a financial outflow is probable.
2. Pending Litigation
The Company's pending litigations comprise of claims against the Company primarily by customers and proceedings pending with tax authorities. The Company has reviewed all its pending litigations and proceedings and has adequately provided for where provisions are required and disclosed the contingent liability (refer note 1 of Schedule 16 (C)) where applicable, in its financial statements. The Company does not expect the outcome of these proceedings to have a material adverse effect on its financial statements as at March 31,2026.
Notes:
i. Physical custody of the securities is with respective clearing houses; however, Company has a right on the contractual cash flows of these investments. These investments can be invoked by the clearing houses in case of any default by the Company in settlement of trades.
ii. No Securities or cash deposited as margin for investment trade obligations are issued outside India.
iii. Margin money is paid to respective counterparties toward negative mark-to-market (MTM losses) on FRA and BFA transactions.
5. Actuarial assumptions
a. All the policies in force and for policies in respect of which premium has been discontinued but liability exists as at March 31, 2026 have been taken into account for this valuation.
The portfolio consists of Participating, Non¬ Participating and Linked segments.
' Participating' segment is further classified in to the following Lines of Businesses (LoBs): Individual - Life - Participating, Individual
- Pension - Participating, Group - Pension - Participating and Individual - VIP - Participating.
Non-Participating' segment is further classified in to the following LoBs: Individual
- Life - Non-Participating, Individual
- Pension - Non-Participating, Group Savings - Non-Participating, Group One Year Renewable Group Term Assurance (OYRGTA) - Non-Participating, Group Other - Non-Participating, Annuity - Non-Participating (Individual and Group), Health - Non-Participating (Individual and Group), and VIP - Non-Participating (Individual and Group).
' Linked' segment is further classified in to the following LoBs: Individual - Life - Linked, Group - Linked and Individual - Pension - Linked.
The assumptions used in valuation of liabilities are in accordance with the guidelines and norms issued by the IRDAI and the Institute of Actuaries of India (IAI) in concurrence with IRDAI.
The actuarial assumptions certified by the Appointed Actuary are as under:
b. The mortality assumptions used based on Company experience and are expressed as percentage of 'Indian Assured Lives Mortality (2012-2014) Ultimate Rates' for life business and 'Indian Individual Annuitant's Mortality Table (2012-15)' for Annuity business. For morbidity assumption, the morbidity rates provided by reinsurers have been used with appropriate adjustments.
The Withdrawal assumptions range from 0% to 26.91% for valuation as at March 31, 2026 as compared to 0% to 25% for valuation as at March 31,2025.
For Non-Participating Group Savings & Group VIP products, expense of 0.165% of fund has been assumed.
An expense inflation rate of 5.50% per annum (previous year ended March 31, 2025: 5.50% per annum) is assumed for fixed per policy/ per member expenses.
For participating products, the vested bonuses are those which were distributed by the Company consequent to the actuarial valuations carried out annually at the end of each financial year dated March 31, 2002 to March 31, 2026. Regarding bonus provisions for the current financial year and bonus provision for future years, the bonus rates have been assessed by carrying out Bonus Earning Capacity (BEC) / asset share investigations and taking into consideration the policyholder's reasonable expectations.
Prevailing tax rate as applicable has been duly allowed for in valuation of policy liabilities.
An appropriate allowance towards Margin for Adverse Deviation has been made while setting the assumptions to ensure prudence in accordance with the APS -7 issued by the Institute of Actuaries of India in concurrence with the IRDAI.
In respect of policies which are in force as at the valuation date and subsequently cancelled during their free-look period, there could be a strain to the extent of the amount payable being higher than the reserve held for that policy. In order to provide for such future strain, an
adequate provision has been made in respect of such policies which are likely to be cancelled during the free-look period basis company's past experience.
In addition to this, Incurred but Not Reported (IBNR) claims reserve is also provided wherever required.
Provision for reinsurance has also been duly allowed for.
Considering the prudence in the valuation basis, our assessment is that the reserve set aside is sufficient to meet all future policy outgoes under adverse conditions.
The Surplus emerged from non-participating segment has been transferred to Profit & Loss Account for the period ended March 31, 2026 based on the recommendation of the Appointed Actuary and the necessary fund transfer will be made after the year end on the basis of Audited financials with required recommendations by the Appointed Actuary.
Funds for Future Appropriation
As at March 31, 2026, the Funds for Future Appropriation (FFA) in non-linked participating segments is f 157,420 Lakhs (previous year ended March 31,2025 f 144,797 Lakhs).
As at March 31, 2026, the Funds for Future Appropriation (FFA) held in linked segments is f 14,645 Lakhs (previous year ended March 31, 2025: f 14,340 Lakhs) in accordance with the IRDAI AFI Regulations 2024 and the IRDAI AFI Master Circular 2024.
6. Cost of guarantee
Provision of f 54,243 Lakhs (previous year ended March 31,2025 f 58,010 Lakhs) has also been made for the cost of guarantee under Individual unit linked policies with guarantee.
7. Policy liabilities
The non-linked policy liability after reinsurance of f 21,251,261 Lakhs as on March 31, 2026 (previous year ended March 31,2025 : f 17,988,323 Lakhs) includes the following non-unit reserve held for linked liabilities:
10. Investments
i. Investments have been made in accordance with the Insurance Act, 1938 as amended by the Insurance Laws (Amendment) Act, 2015, Insurance (Amendment) Act, 2021, the IRDAI AFI Regulations 2024 and IRDAI AFI Master Circular 2024, as amended from time to time.
ii. All investments of the Company are performing investments except as disclosed in Note no. 21(B) of Schedule 16 (C).
The total linked liabilities (excluding non-unit reserve) stands at f 25,894,445 Lakhs as at March 31,2026 (previous year ended March 31,2025: f 24,763,567 Lakhs).
The provisions made towards policy cancellations during free-look period in the year ended March 31, 2026 is f 969 Lakhs. The corresponding amount for the year ended March 31,2025 was f 2,119 Lakhs.
8. Reinsurance or Risk retention
iv. Equity shares lent under the Securities Lending and Borrowing scheme (SLB) continue to be recognised in the Balance Sheet as the Company retains all the associated risk and rewards of these securities. The Fair value of equity shares lent by the Company under SLB and outstanding as at March 31,2026 is f Nil (Previous year ended March 31,2025: f Nil).
In the normal course of its business, the Company seeks to reduce risk exposure by reinsuring certain levels of risk in various areas of exposure with reinsurers. An asset or liability is recorded in the Balance Sheet representing premiums due to or payments due from reinsurers and share of claims recoverable from re- insurers. Extent of risk retained and reinsured is given below:
Qualitative Disclosures
1. Information relating to the composition and mandate of the Nomination and Remuneration Committee
The Board Nomination and Remuneration Committee (NRC) oversees and governs the compensation practices of the Company. The Company's Remuneration Policy is guided by a reward framework and set of principles and objectives as more fully and particularly envisaged under section 178 of Companies Act 2013, Master Circular on Corporate Governance for Insurers, 2024 and SEBI Listing Regulations.
12. Managerial remuneration
Insurance Regulatory and Development Authority of India ('IRDAI' or 'the Authority') has issued Master Circular on Corporate Governance for Insurers, 2024 which replaces and supersedes erstwhile Guidelines on Remuneration of Directors and Key Managerial Persons of Insurer 2023. The IRDAI Master Circular on Corporate Governance for Insurers, 2024 specifies the norms for remuneration of KMPs.
The Managing Director and CEO is on deputation from State Bank of India (SBI) and his remuneration is included under "Employees remuneration and welfare benefits" under "Operating expenses related to insurance business." Further, as per IRDAI Master Circular on Corporate Governance for Insurers, 2024 the remuneration of KMPs of insurers on deputation from PSU promoter are allowed to be governed by their respective remuneration rules/ guidelines of their PSU promoter.
2. Information relating to the design and structure of remuneration policy and the key features and objective of remuneration policy
We follow contribution-oriented philosophy and our compensation is performance-driven, emphasizing and recognizing the contributions made by individual employees. It accentuates performance-based pay, incentives, and shared responsibility for benefits. The key objectives of the remuneration policy are:
• To define and implement overall remuneration philosophy and framework for payment of remuneration payable to Directors (Executive and Non-Executive), Key Managerial Persons and other employees of the Company.
• To ensure that level and composition of remuneration is reasonable and sufficient, relationship of remuneration to performance is clear and meets performance benchmarks. Remuneration shall consist of Fixed Pay including allowances, perquisites, retirement benefits and Variable Pay including incentives, bonus, share linked instruments, joining / sign of bonus, etc.
• To provide to Key Management Persons, Senior Management and other employees rewards linked directly to their effort, performance, dedication and achievement relating to the Company's operations and shall not encourage Key Managerial Persons to take inappropriate or excessive
risks for their performance based variable remuneration.
• To retain, motivate and promote talent and to ensure long term sustainability of talented managerial persons and create competitive advantage.
• To ensure alignment of compensation with prudent risk taking.
The policy is reviewed by Board NRC annually or as and when required.
3. Description of the ways in which current and future risks are taken into account in the remuneration policy including the nature and type of the key measures used to take account of these risks
The Remuneration policy promotes sound and prudent risk management. Remuneration structure is well aligned with the long-term growth, health and objectives of the company. Compensation outcomes are symmetric with risk outcomes and pay-outs thereof are sensitive to the time horizon of the risk and the mix of cash, equity and other forms of remuneration are consistent with risk alignment.
The Remuneration policy of the Company ensures proper balance between fixed pay and variable pay. Variable Pay is in the form of "pay at risk" and depending on performance and risk outcomes at individual and company-wide level, the quantum of Variable Pay changes.
As per the Remuneration policy, which is aligned with IRDAI circular, for Key Managerial Persons, at least 50% of the total variable pay is under deferral arrangement and the deferral is spread over at least three years. The deferred variable pay is also subject to Malus and Claw-Back clauses as detailed in the Remuneration Policy of the Company.
4. Description of ways in which the insurer seeks to link performance, during a performance measurement period, with levels of remuneration.
The Company has an annual increment and variable pay policy which is based on merit pay
philosophy linked to both individual as well as Company's performance.
Various performance parameters for the Company are reviewed by Board NRC and approved by the Board every year. Based on the actual performance, the Company performance rating is approved by the Board based on the recommendations of Board NRC after the end of every financial year.
The framework of annual increment and performance linked Variable Pay for all employees is reviewed by the Board NRC and approved by the Board every year.
Income tax provisions involves significant judgments in determining the provision for income taxes including judgment on whether tax positions are probable of being sustained in tax assessments. The Management periodically reassess and evaluates tax position with respect to applicable tax law based on the existing facts and circumstances.
16. Operating lease arrangements (a) Assets taken on operating lease:
In accordance with Accounting Standard 19 on 'Leases', the details of leasing arrangements entered into by the Company are as under:
The Company has entered into agreements in the nature of lease or leave and licence with different lessors or licensors for residential premises, office premises and motor vehicles. These are in the nature of operating lease. Some of these lease arrangements contain provisions for renewal and escalation. There are no restrictions imposed by lease arrangements nor are there any options given to the Company to purchase the properties and the rent is not determined based on any contingency.
The operating lease rentals charged to the Revenue Account during the year and future minimum lease payments as at the Balance Sheet date are as follows:
14. Investments of funds and assets pertaining to policyholders' liabilities a. Allocation of investments between policyholders' funds and shareholders' funds
Investments made out of the shareholders' and policyholders' funds are tracked from inception and income accordingly accounted for on the basis of records maintained. As and when necessary, transfers have been made from shareholders' investments to policyholders' investments. In respect of such transfers, the investment income is allocated from the date of transfer.
17. Earnings per share
In accordance with Accounting Standard 20 on 'Earning per share', basic earnings per share are calculated by dividing the net profit or loss in the shareholders' account by the weighted average number of equity shares outstanding during the year.
For the purpose of calculating diluted earnings per share, the net profit or loss for the year attributable to shareholders and the weighted average number of shares outstanding during the year are adjusted for the effects of all dilutive potential equity shares. Potential equity shares are deemed to be dilutive only if their conversion to equity shares would decrease the net profit per share from continuing ordinary operations.
19. Employee benefits a. Defined Benefit Plans:
(i) Gratuity
Gratuity is funded defined benefit plan for qualifying employees under which the Company makes a contribution to the SBI Life Insurance Company Limited Employees Gratuity Fund. The plan provides for a lump sum payment as determined in the manner specified under The Payment of Gratuity Act, 1972, to the vested employees either at retirement or on death while in employment or on termination of employment. The benefit vests after five years of continuous service. Defined benefit obligations are actuarially determined at each Balance Sheet date using the projected unit credit method (PUCM) as per Accounting Standard 15 (Revised), "Employee benefits". Actuarial gains and losses are recognised in the Revenue Account.
(ii) Provident Fund
The rules of the Company's Provident Fund administered by a Trust require that if the Board of Trustees are unable to pay interest at the rate declared for Employees' Provident Fund by the Government under para 60 of the Employees' Provident Fund Scheme, 1952 for the reason that the return on investment is less or for any other reason, then the deficiency shall be made good by the Company. Based on an actuarial valuation conducted by an independent actuary, the details of provident fund are as below.
(iv) Other long term benefits
The Company accrues the liability for compensated absences and long term service awards in accordance with Accounting Standard - 15 (Revised). The net present value of the Company's obligation is determined based on the projected unit credit method as at the Balance Sheet date.
c. Employee Stock Option Scheme (ESOS)
(iii) Employee COVID Ex-gratia
The Company accrues liability for Employees COVID Ex-gratia Scheme in accordance with Accounting Standard - 15 (Revised) on Employee Benefits. The Net Present Value (NPV) of the Company's obligation is actuarially determined based on the Projected Unit Credit Method (PUCM) as at the Balance Sheet date. The COVID Ex-gratia Scheme has ended on March 31,2022. The details of Employee COVID Ex-gratia Scheme are as below:
The SBI Life Employee Stock Option Plan 2018 ('ESOP 2018') and SBI Life Employees Stock Option Scheme 2018 ('the Scheme' or 'ESOS 2018') has been approved by the shareholders of the Company in the Annual General Meeting (AGM) held on September 27, 2018 based on the recommendation of the Board Nomination & Remuneration Committee ('NRC') and Board of Directors ('Board') in their meetings held on August 31,2018.
The maximum number of stock options granted to eligible employees in accordance with ESOP 2018 shall not exceed 30,000,000 shares. During any one year, no employee shall be granted Options equal to or exceeding 1% of the issued share capital of the Company at the time of Grant of Options unless an approval from the Shareholders is taken by way of special resolution in a General Meeting. Further, the maximum number of Options in aggregate granted to an employee under this Plan shall not exceed 1,00,00,000 Options. The Exercise Price shall be determined by the Board Nomination & Remuneration Committee in concurrence with the Board of Directors of the Company on the date the Options are granted and provided in the letter of grant.
The Scheme is directly administered by the Company and provides that eligible employees are granted options to subscribe to equity shares of the Company which vest in a graded manner. The vested options may be exercised within a specified period.
The Company follows intrinsic value method to account for its share-based employee compensation plans. During the year ended March 31,2026, the Company has granted 830,000 options to its eligible employees under ESOS 2018. Out of the total 3,287,122 options outstanding as at previous year ended March 31, 2025, 661,170 options are vested during the year ended March 31,2026.
During the year ended March 31,2026, 957,038 stock options are exercised (previous year ended March 31,2025, 669,618 stock options). The details of ESOPs with respect to option exercised during the year & compensation cost recognised are as follows:
20. Accounting for diminution in valuation of investments
A. Equity:
The Company has made the provision for diminution in value of investments on a prudent basis for loss on account of reduction in market values of long term investment in equities as under:
21. Provision for Standard assets and Non-Standard assets for debt portfolio
In accordance with the 'Guidelines on Prudential norms for income recognition, Asset classification, Provisioning and other related matters in respect of Debt portfolio' as specified by IRDAI vide the Master Circular dated May 17, 2024, provision for standard assets and non-standard assets has been recognized as follows: -
22. Investment Properties - Real Estate Investment Trusts (REITs)
The investment in Real Estate Investment Trusts (REIT's) of f 222,931 Lakhs as at year ended March 31, 2026 (Previous year ended March 31, 2025 f 131,338 Lakhs) has been disclosed as part of the Investment Property in accordance with the IRDAI AFI Master Circular 2024 and the IRDAI AFI Regulations 2024 under schedule 8 and 8A of the Financial Statements.
23. Derivatives
The Company offers guaranteed products wherein the Policyholders are assured of a fixed rate of return for premiums to be received in future. These premiums are likely to be received over a longer tenure and the guaranteed rate of return is fixed at the beginning of the policy term. Any fall in interest rates would mean that each incremental investment of the Company would earn a lower rate of return. Accordingly, the Company manages the Interest Rate Risk in accordance with the IRDAI AFI Master Circular 2024 and the IRDAI AFI Regulations 2024 (as amended) which allows insurers to deal in rupee interest rate derivatives such as Forward Rate Agreements ("FRAs"), Interest Rate Swaps ("IRS") and Exchange Traded Interest Rate Futures ("IRF"), and Bond Forward Agreements (BFAs).
The Company has in place a derivative policy approved by Board which covers various aspects that apply to the functioning of the derivative transactions undertaken to substantiate the hedge strategy to mitigate the interest rate risk, thereby managing the volatility of returns from future fixed income investments, due to variations in market interest rates.
The Company enters into Forward Rate Agreements (FRAs) / Bond Forward Agreements (BFAs) transactions, as part of its Hedging strategy, to hedge the interest rate sensitivity for highly probable forecasted transactions as permitted by the IRDAI circular on Interest Rate Derivatives and IRDAI circular on Exposure to Forward Contracts in Government Securities.
Interest Rate derivative contracts (FRAs / BFAs) are over-the-counter (OTC) derivative contracts wherein, the Company lock-in the yield on the government bond for the period till the maturity of the contract with an objective to lock in the price of an interest-bearing security at a future date.
Derivatives (FRA / BFA) are undertaken by Company solely for the purpose of hedging interest rate risks on account of following forecasted transactions: a) Reinvestment of maturity proceeds of existing fixed income investments; b) Investment of interest income receivable; and c) Expected policy premium income receivable on insurance contracts which are already underwritten in Life, Pension & Annuity business.
vii. A net amount of ?(52,237) Lakhs for the year ended March 31, 2026 (Previous year ended March 31, 2025 ?(7,072) Lakhs) has recognized in Revenue Account being portion of loss determined to be ineffective.
viii. The amount that was removed from Hedge Reserve account during the year ended March 31,2026 in respect of forecast transaction for which hedge accounting had previously been used, but is no longer expected to occur is ? Nil (Previous year ? Nil). The cash flows from the hedges are expected to occur over the outstanding tenure of underlying policy liabilities and will accordingly flow to the Revenue Account.
B. Qualitative Disclosures on risk exposure in Fixed Income Derivatives:
Overview of business and processes:
a) Fixed Income Derivative Hedging instruments:
Derivatives are financial instruments whose characteristics are derived from the underlying assets, or from interest and exchange rates or indices. These include forward rate agreements, interest rate swaps and interest rate futures.
The Company during the financial year has entered into FRA and BFA derivative instrument to minimise exposure to fluctuations in interest rates on plan assets and liabilities. This hedge is carried in accordance with its established policies, strategy, objective and applicable regulations. The Company does not engage in derivative transactions for speculative purposes.
b) Derivative policy/process and Hedge effectiveness assessment:
The Company has well defined Board approved Derivative Policy and Process document setting out the strategic objectives, regulatory and operational framework and risks associated with interest rate derivatives along with having measurement, monitoring processes and controls thereof. The accounting policy has been clearly laid out for ensuring a process of periodic effectiveness assessment and accounting.
The Company has clearly identified roles and responsibilities to ensure independence and accountability through the investment decision, trade execution, to settlement, accounting and periodic reporting and audit of the Interest Rate Derivative exposures. The risk management framework for the Interest Rate Derivatives are monitored by the Risk Management Committee.
c) Scope and nature of risk identification, risk measurement, and risk monitoring:
The Derivative and related Policies as approved by the Board sets appropriate market limits such as sensitivity limits and value-at-risk limits for exposures in interest rate derivatives. All financial risks of the derivative portfolio are measured and monitored on periodic basis.
C. Quantitative disclosure on risk exposure in Forward Rate Agreement
A hedge is deemed effective, if it has a high statistical correlation between the change in value of the hedged item and the hedging instrument (FRA and BFA). Gains or losses arising from hedge ineffectiveness, if any, are recognised in the Revenue Account.
The credit exposure limit for FRA and BFA derivatives has been calculated on the basis of Credit Equivalent Amount using the Current Exposure Method (CEM) as detailed below:
The Credit Equivalent Amount of a market related off-balance sheet transaction calculated using the CEM is the sum of
a) the current credit exposure (gross positive mark to market value of the contract); and
b) potential future credit exposure which is a product of the notional principal amount across the outstanding contract and a factor that is based on the mandated credit conversion factors as prescribed under the IRDAI circular on Interest Rate Derivatives, which is applied on the residual maturity of the contract.
24. Micro, Small and Medium Enterprises Development Act, 2006
Under the Micro, Small and Medium Enterprises Development Act, 2006 and amendments made thereafter, certain disclosures are required to be made relating to Micro, Small and Medium Enterprises.
According to information available with the management, on the basis of intimation received from suppliers, regarding their status under the Micro, Small and Medium Enterprises Development Act, 2006 (MSMED Act) and amendments made thereafter, the Company has amounts due to Micro and Small Enterprises under the said Act as follows:
iv. Financial performance including growth rate and current financial position of the insurer
Refer summary of financial statement and ratios.
v. A description of the risk management architecture
The Board has the ultimate responsibility for overseeing the management of risk within the Company. The Risk profile of the Company is reported to the Board by the Risk Management Committee of the Board (RMC-B) from time to time. The RMC-B is responsible for overseeing the Company's risk management program and for ensuring that significant risks to the Company are reported to the Board on a timely basis and apprise the Board of the various risk management strategies being adopted. The Company's Risk Appetite statement and the Annual Risk assessment are reviewed by the Board so as to ensure that the business of the Company is carried out within the set risk limits.
The RMC-B is supported by Risk Management Committee of the Executives (RMC-E) and the Asset Liability Committee (ALCO). The RMC-E oversees the enterprise wide risk management activities and the ALCO monitors insurance and investment risk portfolio.
The Company has an Information Security Risk Management Committee (ISRMC) which oversees all information and cyber security risks and its control. The Company has constituted a Data Governance Committee (DGC) to oversee formulation and implementation of data governance framework / policies / procedures in the Company.
The Company also has a Risk Event Monitoring Committee (REMC) which primarily oversees reputational risks and other significant external risk events. Minutes of the ISRMC, DGC and REMC meetings are put up to RMC-E for information.
25. Additional disclosure requirements as per Corporate Governance Guidelines
i. Quantitative and qualitative information on the insurer's financial and operating ratios, namely, incurred claim, commission and expenses ratios:
Refer summary of financial statement and ratios.
ii. Actual solvency margin details vis-a-vis the required solvency margin
The actual solvency margin of the Company as on March 31, 2026 stands at 1.90 times (previous year ended March 31, 2025: 1.96 times) as against regulatory requirement of 1.50. There has been no capital infusion after FY 2007-08.
iii. Persistency ratio
The persistency ratio (13th month) for regular premium and limited premium paying term policies of Individual segment for the year ended March 31,2026 is 87.94% (previous year ended March 31,2025 is 87.41 %) based on premium amount and 81.54% (previous year ended March 31,2025 is 80.45%) based on number of policies.
The persistency ratios are calculated as per IRDAI circular reference IRDAI/NL/MSTCIR/RT/93/6/2024 dated June 14, 2024.
Persistency ratios for the year ended March 31,2026 and March 31,2025 are calculated using policies issued in 1st March to 28th/29th February of the relevant years.
x. Deposits made under Local laws
The Company has no deposit as at March 31,2026 (previous year ended March 31,2025: Nil) made under local laws or otherwise encumbered in or outside India, except investments and deposits detailed in Note 3(b) of Schedule 16(C).
26. Age-wise analysis for policyholders' - unclaimed amount
In accordance with IRDAI Master Circular on Operation and Allied Matters of Insurers dated June 19, 2024 and IRDAI AFI regulation 2024 read with rule 3 (6) of Senior Citizens' Welfare Fund Rules, 2016, the unclaimed of policyholders for a period of more than 10 years (i.e. more than 120 months) as on 30th September, every year, will be transferred to the Senior Citizens' Welfare Fund (SCWF) on or before 1st March of that financial year.
In accordance with IRDAI Master Circular on Operation and Allied Matters of Insurers dated June 19, 2024 and IRDAI AFI regulation 2024, the Company maintains a single segregated fund to manage all unclaimed amounts. The amount is invested in money market instruments, liquid mutual funds and fixed deposits of scheduled banks.
The amount in the unclaimed fund has been disclosed in schedule 12 as "Assets held for unclaimed amount of policyholders" along with "Income accrued on unclaimed fund". Income on unclaimed amount of policyholders is accreted to the unclaimed fund and is accounted for on an accrual basis, net of fund management charges, and is disclosed under the head "Interest on unclaimed amounts" in Schedule 4 "Benefits paid" in Revenue account.
28. Contribution made by the shareholders' to the policyholders' account
The contribution of ? 187,393 Lakhs (previous year ended March 31, 2025: ' 134,591 Lakhs) made by the shareholders' to the policyholders' account is irreversible in nature, and shall not be recouped to the shareholder's account at any point of time.
29. Foreign Exchange gain/ (loss)
The amount of foreign exchange gain/ (loss) in Revenue Account and Profit & Loss account is as follows:
35. Long term contracts
The Company has a process whereby periodically all long term contracts are assessed for material foreseeable losses. At the year end, the Company has reviewed and ensured that adequate provisions as required under any law/ accounting standard for material foreseeable losses on such long term contracts including derivative contracts has been made in the financial statements.
For insurance contracts, actuarial valuation of liabilities for all the policies which were in the books of the Company and where there is a liability as at March 31, 2026 is done by the Appointed Actuary of the Company. The assumptions used in valuation of liabilities are in accordance with the guidelines and norms issued by the IRDAI and the Institute of Actuaries of India (IAI) in concurrence with IRDAI.
36. Interim Dividend
The Board of Directors at its meeting held on February 25, 2026 has declared and paid Interim Dividend of ? 2.7 per share amounting to ? 27,081 Lakhs for the year ended March 31,2026 (previous year ended March 31, 2025: ? 2.7 per share amounting to ? 27,057 Lakhs).
37. Corporate Social Responsibility
The Company has spent f 2,001 Lakhs for the year ended March 31,2026 (previous year ended March 31,2025 f 1,990 Lakhs) towards Corporate Social Responsibility activities mentioned in Schedule VII of the Companies Act, 2013.
38. Linked Business
Financial statements, for each segregated fund of the linked businesses, is presented in ULIP Disclosures as per the IRDAI AFI Master Circular 2024. Segregated funds represent funds maintained in accounts to meet specific investment objectives of policyholders who bear the investment risk. Investment income/ gains and losses generally accrue directly to the policyholders. The assets of each account are segregated and are not subject to claims that arise out of any other business of the insurer.
39. Ind AS update
International Accounting Standard Board ('IASB') has notified the amended IFRS 17, with global date of implementation starting from January 1, 2023. The Institute of Chartered Accountants of India ('ICAI') has issued exposure draft of amendments in Ind AS 117 on 8th February, 2022. The Ministry of Corporate Affairs (MCA) vide its notification dated August 12, 2024 has notified the Ind AS 117 on Insurance Contracts. Further, on September 28, 2024, the MCA has issued a notification that insurance company may provide its financial statements as per Ind AS 104 for the purpose of consolidated financial statements till IRDAI notifies the Ind AS 117. The IRDAI ('the Authority') vide its communication dated July 14, 2022 on Ind AS implementation in Insurance Sector has conveyed its broad approach on Ind AS implementation and necessary steps to be initiated by the insurers. On 3 March 2026, IRDAI issued the Exposure Draft of the IRDAI (Actuarial, Finance and Investment Functions of Insurers) (Amendment) Regulations, 2026, proposing mandatory adoption of Indian Accounting Standards (Ind AS) by all insurers with effect from 1 April 2026. Thereafter, on 30 March 2026, IRDAI notified the IRDAI (Actuarial, Finance and Investment Functions of Insurers) (Amendment) Regulations, 2026, mandating preparation and presentation of financial statements in accordance with applicable Ind AS, including Ind AS 117, with effect from 1 April 2026. The Regulations, inter alia, provide one year forbearance, at the discretion of IRDAI, for insurers facing implementation challenges, subject to submission of a Board approved Ind AS transition plan with defined milestones and quarterly submission of Ind AS financial information to IRDAI during the forbearance period.
As per the directions of Authority, the Company has constituted Steering Committee headed by President & CFO and members from cross-functional areas such as actuarial, investment, information technology. The Company has engaged knowledge partner for Ind AS implementation. The Ind AS Gap and impact assessment is completed. The Company has prepared and submitted to the Authority Ind AS Proforma Financial information for the FY 2023-24 and FY 2024-25. The Company is currently in the process of preparing the Proforma Ind AS Financial information for the year ended March 31, 2026, along with quarterly Ind AS proforma financial information, for submission to IRDAI in line with stipulated regulatory timelines. The Company is currently in the process of evaluation and finalization of the system for Ind AS implementation. The Audit Committee and Board of Directors have been updated regularly on status update of Ind AS implementation.
40. Remuneration to Non-Executive Directors
No remuneration or commission is paid to Non-Executive Directors, other than the Sitting Fees for attending Board and/or its Committee meetings. The amount of sitting fees paid to the Non-Executive Directors is disclosed in Profit and Loss (Shareholders) Account.
41. Refund of Administrative fees as per IRDAI directions
IRDAI has issued directions under section 34(1) of the Insurance Act, 1938 to distribute the administrative charges paid to master policyholders amounting to ?8,432 Lakhs vide its order no. IRDA/Life/ORD/MISC/228/10/2012 dated October 5, 2012 and subsequent order no. IRDA/Life/ORD/MISC/009/01/2017 dated January 11,2017. The Securities Appellate Tribunal (SAT) vide its order dated April 7, 2021 has dismissed the appeal filed by the Company against the IRDAI order. Subsequently, the Hon'ble Supreme Court vide its order dated September 22, 2021 has dismissed petition filed by the Company against the SAT order. Accordingly, in FY 2022, the Company has made provision in the Profit and Loss Account (Shareholders' Account) for refund of administrative charges paid to group master policy holders amounting to ? 8,432 Lakhs plus applicable interest as per IRDAI order dated January 11,2017. As at March 31,2026, out of the total provision amount, the Company has refunded administrative fees of ? 5,746 Lakhs along with interest of ? 2,358 Lakhs (As at March 31,2025 administrative fees of ? 5,665 Lakhs and interest of ? 2,299 Lakhs) to the members of group insurance policy.
42. Status update on Sahara Life Insurance Company Limited
Insurance Regulatory and Development Authority of India ('IRDAI') vide its order dated June 2, 2023 ('IRDAI order') passed in terms of section 52B (2) of the Insurance Act, 1938 has directed to transfer the life insurance business of Sahara India Life Insurance Company Limited ('SILIC') involving policy liabilities and policyholders' investment/ assets to SBI Life Insurance Company Limited ('SBI Life' or 'the Company').On appeal filed by SILIC against the said IRDAI order, the Securities Appellate Tribunal ('SAT' or 'Tribunal') vide its order dated June 13, 2023 has granted stay on the effect and operation of the said IRDAI order. Subsequently, the IRDAI has filed an appeal with Hon'ble Supreme Court against the stay order passed by SAT. The Hon'ble Supreme Court in its hearing held on July 17,
2023 has set aside Securities Appellate Tribunal's (SAT) stay and directed the SAT to hear the case and decide it afresh. Thereafter, the SAT, vide its order dated December 5, 2025, has dismissed the appeal filed by SILIC and upheld the order passed by the IRDAI dated June 2, 2023 therefore the order is no longer sub judice. The Company has initiated steps to seek directions from the IRDAI for complying with the IRDAI order dated June 2, 2023.
The Company has received the premium of ? 3,777 Lakhs (excluding GST) up to March 31, 2026 (for FY 2025-26 ? 1,088 Lakhs) and processed the claim pay-outs of ? 29,377 Lakhs till March 31, 2026 (for FY 2025-26 ? 14,982 Lakhs). The Company has discharged GST liability of ? 125 Lakhs on premium and charges up to March 31,2026 (for FY 2025-26 ? 32 Lakhs) and TDS payment of ? 182 Lakhs on claim pay-out till March 31,2026 (for FY 2025-26 ? 36 Lakhs). As on March 31,2026, the Company has total SILIC investment assets with book value of ? 123,770 Lakhs (Market value of ? 132,748 Lakhs) and Bank balance of ? 91 Lakhs. The Company maintains separate records of all transactions pertaining to SILIC and prepares special purpose financial statements, which are audited and submitted to the Authority.
The overall impact of the aforesaid IRDAI order with respect to SILIC will be given in the Company's financial statements in accordance with any further directions issued by the Authority.
45. Segment reporting
In accordance with the IRDAI AFI Regulations 2024 read with Accounting Standard - 17 on "Segment reporting", life insurance companies are required to prepare Segmental Revenue Account and Segmental Balance Sheet. The Company's business is segmented into traditional -par business, non-par business and unit-linked business. Since the Company has conducted business only in India, the same is considered as one geographical segment. The accounting policies used in segmental reporting are same as those used in the preparation of the financial statements.
(a) Segmental Revenue Account
The methodology for determining segmental revenue and expenses adopted in the current year is described below:
Premium income, commission, investment income and profit or loss on sale or disposal of investments is directly allocated to the respective segments to which they relate. Within the Non-Participating segment, investment income and profit or loss on sale or disposal of investments are directly allocated if a segregated investment portfolio is maintained. The remaining investment income and profit or loss on sale of investments is apportioned on the basis of the average policy liabilities in the individual business and the group business.
Operating expenses that are directly attributable and identifiable to the business segments are allocated on actual basis. Other operating expenses, which are not directly identifiable and attributable, are allocated after considering the following:
i. Cost centres identified by the Management
ii. Channels used for the business segments
iii. Annualised Premium Equivalent (APE)
iv. New lives covered / New policies issued during the year
v. Total number of in-force lives covered
vi. New business sum assured
vii. Actuarial Liability
(b) Segmental Balance Sheet
Investments are effected from the respective funds and have been reflected accordingly. Fixed assets have been allocated to shareholders' funds, net current assets have been directly allocated among shareholders, life business, pension business, group business, unit - linked business and variable insurance business segments. Other net current assets have been allocated to life business and pension business in the ratio of the respective policy liabilities as at the year end.
Within life business, certain assets and liabilities have been directly identified to the respective segments. Other assets and liabilities under Life business have been allocated in the ratio of the respective policy liabilities as at the year end.
The accounting policies used in segment reporting are the same as those used in the preparation of the financial statements.
46. No funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or any other person or entities, including foreign entities ('Intermediaries') with the understanding, whether recorded in writing or otherwise, that the Intermediary shall lent or invest in party identified by or on behalf of the Company (Ultimate beneficiaries). The Company has also not received any fund from any parties (Funding Party) with the understanding that the Company shall whether, directly or indirectly lent or invest in other persons or entities identified by or on behalf of the Funding Party ('Ultimate Beneficiaries') or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.
47. On November 21, 2025, the Government of India notified Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively, the "Labour Codes"). The Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations. The Company has evaluated the financial impact of the Labour Codes basis the FAQs of the Ministry of Labour & Employment and recognised incremental estimated liabilities towards employees' past service benefits, determined based on actuarial valuation in accordance with AS 15 - Employee Benefits and guidance issued by the Institute of Chartered Accountants of India (ICAI). The resulting incremental charge of ? 13,549 lakh has been recognised in the Revenue Account for the year ended March 31, 2026. The Company continues to monitor developments related to the Labour Codes and will assess any further impact on the measurement of employee benefits liabilities as and when they arise.
48. Previous year figures regrouped / reclassified
Previous year figures have been regrouped / reclassified / rearranged wherever necessary to make them comparable with current year's presentation.
|